(Q43442033)

English

Cognitive and affective disorders associated to HIV infection in the HAART era: findings from the NeuroICONA study. Cognitive impairment and depression in HIV/AIDS. The NeuroICONA study

scientific article published in July 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Cognitive and affective disorders associated to HIV infection in the HAART era: findings from the NeuroICONA study. Cognitive impairment and depression in HIV/AIDS. The NeuroICONA study (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

cognitive dysfunction

1 reference

based on heuristic

inferred from title

Giuseppe Ippolito

6

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Patrizio Pezzotti

21

object named as

Pezzotti P

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Antonella d'Arminio Monforte

22

object named as

D'Arminio Monforte A

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Maria Cristina Moioli

8

object named as

Moioli MC

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

author name string

Starace F

1

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Bartoli L

2

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Aloisi MS

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Antinori A

4

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Narciso P

5

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Ravasio L

7

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Vangi D

9

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Gennero L

10

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Coronado OV

11

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Giacometti A

12

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Nappa S

13

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Perulli ML

14

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Montesarchio V

15

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

La Gala A

16

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Ricci F

17

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Cristiano L

18

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

De Marco M

19

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Izzo C

20

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

language of work or name

0 references

publication date

1 July 2002

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Acta Psychiatrica Scandinavica

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

106

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

20-26

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

21 January 2018

Clinical and spectroscopic improvement in HIV-associated cognitive impairment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

21 January 2018

Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

21 January 2018

Depressive symptoms decline among persons on HIV protease inhibitors.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

21 January 2018

Impact of psychiatric conditions on health-related quality of life in persons with HIV infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

21 January 2018

An investigation of why eligible patients do not receive HAART.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

21 January 2018

Mild cognitive impairment and risk of mortality in HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

21 January 2018

Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

21 January 2018

Early neuropsychological impairment in HIV-seropositive intravenous drug users: evidence from the Italian Multicentre Neuropsychological HIV Study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

21 January 2018

WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

21 January 2018

Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

21 January 2018

Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

21 January 2018

Depressive symptoms reduced in individuals with HIV/AIDS treated with highly active antiretroviral therapy: a longitudinal study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

21 January 2018

Predictors of Virological Success and Ensuing Failure in HIV-Positive Patients Starting Highly Active Antiretroviral Therapy in Europe

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

21 January 2018

HIV infection and dementia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacotherapy of HIV dementia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Depressive symptoms reduced in individuals with HIV/AIDS treated with highly active antiretroviral therapy: a longitudinal study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection: impact on medical, palliative care, and quality of life outcomes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: a WHO study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02289.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1600-0447.2002.02289.X

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43442033&oldid=1988899418"